Emerson M Wickwire1,2, M Doyinsola Bailey3, Virend K Somers4, Mukta C Srivastava5, Steven M Scharf2, Abree M Johnson6, Jennifer S Albrecht3. 1. Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland. 2. Sleep Disorders Center, Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland. 3. Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland. 4. Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota. 5. Division of Cardiovascular Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland. 6. Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland.
Abstract
STUDY OBJECTIVES: To examine the impact of adherence to continuous positive airway pressure (CPAP) therapy on risk of stroke among a nationally representative sample of older adults with obstructive sleep apnea. METHODS: We performed a retrospective cohort study among Medicare beneficiaries aged ≥ 65 years who were newly diagnosed with obstructive sleep apnea and had initiated CPAP (2009-2013). Monthly indicators of CPAP adherence included charges for machines, masks, or supplies and were summed over a 25-month follow-up to create a CPAP adherence variable. Stroke was modeled as a function of CPAP adherence using generalized estimating equations. RESULTS: We found that 5,757 beneficiaries met the inclusion criteria and were included in the final sample. Of these, 407 (7%) experienced stroke. After adjusting for demographic and clinical characteristics, CPAP adherence was associated with a reduced risk of stroke (hazard ratio, 0.98; 95% confidence interval, 0.96-0.99) over 25 months, indicating a 2% reduction in risk of stroke for each month of CPAP adherence. When sensitivity analyses were performed to stratify results by time since the first CPAP charge, the protective effect remained significant for the 12- and 6-month but not the 3-month outcome models. CONCLUSIONS: In this national analysis of older adult Medicare beneficiaries with obstructive sleep apnea, CPAP adherence was associated with significantly reduced risk of stroke.
STUDY OBJECTIVES: To examine the impact of adherence to continuous positive airway pressure (CPAP) therapy on risk of stroke among a nationally representative sample of older adults with obstructive sleep apnea. METHODS: We performed a retrospective cohort study among Medicare beneficiaries aged ≥ 65 years who were newly diagnosed with obstructive sleep apnea and had initiated CPAP (2009-2013). Monthly indicators of CPAP adherence included charges for machines, masks, or supplies and were summed over a 25-month follow-up to create a CPAP adherence variable. Stroke was modeled as a function of CPAP adherence using generalized estimating equations. RESULTS: We found that 5,757 beneficiaries met the inclusion criteria and were included in the final sample. Of these, 407 (7%) experienced stroke. After adjusting for demographic and clinical characteristics, CPAP adherence was associated with a reduced risk of stroke (hazard ratio, 0.98; 95% confidence interval, 0.96-0.99) over 25 months, indicating a 2% reduction in risk of stroke for each month of CPAP adherence. When sensitivity analyses were performed to stratify results by time since the first CPAP charge, the protective effect remained significant for the 12- and 6-month but not the 3-month outcome models. CONCLUSIONS: In this national analysis of older adult Medicare beneficiaries with obstructive sleep apnea, CPAP adherence was associated with significantly reduced risk of stroke.
Authors: Virend K Somers; David P White; Raouf Amin; William T Abraham; Fernando Costa; Antonio Culebras; Stephen Daniels; John S Floras; Carl E Hunt; Lyle J Olson; Thomas G Pickering; Richard Russell; Mary Woo; Terry Young Journal: J Am Coll Cardiol Date: 2008-08-19 Impact factor: 24.094
Authors: Emerson M Wickwire; M Doyinsola Bailey; Virend K Somers; Mukta C Srivastava; Steven M Scharf; Abree M Johnson; Jennifer S Albrecht Journal: Sleep Breath Date: 2020-11-03 Impact factor: 2.816
Authors: Naresh M Punjabi; Eyal Shahar; Susan Redline; Daniel J Gottlieb; Rachel Givelber; Helaine E Resnick Journal: Am J Epidemiol Date: 2004-09-15 Impact factor: 4.897
Authors: Miguel-Angel Martínez-García; Francisco Campos-Rodríguez; Pablo Catalán-Serra; Juan-José Soler-Cataluña; Carmen Almeida-Gonzalez; Ines De la Cruz Morón; Joaquin Durán-Cantolla; Josep-Maria Montserrat Journal: Am J Respir Crit Care Med Date: 2012-09-13 Impact factor: 21.405
Authors: Emerson M Wickwire; Sarah E Tom; Aparna Vadlamani; Montserrat Diaz-Abad; Liesl M Cooper; Abree M Johnson; Steven M Scharf; Jennifer S Albrecht Journal: J Clin Sleep Med Date: 2019-12-05 Impact factor: 4.062
Authors: Sara J E Beishuizen; Barbara C van Munster; Annemarieke de Jonghe; Ameen Abu-Hanna; Bianca M Buurman; Sophia E de Rooij Journal: J Am Geriatr Soc Date: 2017-02-02 Impact factor: 5.562
Authors: Joshua M Bock; Keith A Needham; David A Gregory; Mercedes M Ekono; Emerson M Wickwire; Virend K Somers; Amir Lerman Journal: Mayo Clin Proc Innov Qual Outcomes Date: 2022-04-04
Authors: Jakub Mochol; Jakub Gawrys; Damian Gajecki; Ewa Szahidewicz-Krupska; Helena Martynowicz; Adrian Doroszko Journal: Int J Mol Sci Date: 2021-05-12 Impact factor: 5.923